Table 2. Association between MET and p-MET expression and clinical variables.
|
Total MET expression
|
p-MET expression
|
|||||
|---|---|---|---|---|---|---|
| POS | NEG | P-value | POS | NEG | P-value | |
| Gender | ||||||
| Female | 5 | 4 | 0.948 | 3 | 6 | 0.539 |
| Male | 37 | 31 | 30 | 38 | ||
| Smoking history | ||||||
| Previous/never | 16 | 8 | 0.253 | 8 | 16 | 0.453 |
| Current | 25 | 27 | 24 | 28 | ||
| PS | ||||||
| 0–1 | 29 | 19 | 0.544 | 21 | 27 | 0.855 |
| 2–3 | 8 | 5 | 5 | 8 | ||
| Stage | ||||||
| Limited | 15 | 17 | 0.381 | 9 | 23 | 0.048 |
| Extensive | 24 | 18 | 21 | 21 | ||
Abbreviations: NEG=negative; p-MET=phosphorylated MET; POS=positive; PS=performance status.